Vasopressin and methylprednisolone for in-hospital cardiac arrest — Protocol for a randomized, double-blind, placebo-controlled trial

Objective: To describe the clinical trial “Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest” (VAM-IHCA). Methods: The VAM-IHCA trial is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of vasopressin and methylpr...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Lars W. Andersen, Birthe Sindberg, Mathias Holmberg, Dan Isbye, Jesper Kjærgaard, Stine T. Zwisler, Søren Darling, Jacob Moesgaard Larsen, Bodil S. Rasmussen, Bo Løfgren, Kasper Glerup Lauridsen, Kim B. Pælestik, Christoffer Sølling, Anders G. Kjærgaard, Dorte Due-Rasmussen, Fredrik Folke, Mette Gitz Charlot, Kasper Iversen, Martin Schultz, Sebastian Wiberg, Rikke Malene H.G. Jepsen, Tobias Kurth, Michael Donnino, Hans Kirkegaard, Asger Granfeldt
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2021-03-01
Reeks:	Resuscitation Plus
Onderwerpen:	In-hospital cardiac arrest Vasopressin Methylprednisolone Randomized trial
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2666520421000060
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!